leukemia
|
0.040 |
Biomarker
|
disease |
BEFREE |
The increase in Op18 polypeptide in leukemia is associated with increased RNA transcription without gene amplification or rearrangement.
|
1917919 |
1991 |
Childhood Leukemia
|
0.040 |
Biomarker
|
disease |
BEFREE |
The increase in Op18 polypeptide in leukemia is associated with increased RNA transcription without gene amplification or rearrangement.
|
1917919 |
1991 |
Acute leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Our findings suggest that the high amount of Op18 protein in acute leukemia results from increased expression of a structurally unaltered gene.
|
1917919 |
1991 |
Neuroblastoma
|
0.060 |
PosttranslationalModification
|
disease |
BEFREE |
Our findings provide evidence for distinct patterns of Op18 phosphorylation in neuroblastoma tumors with and without N-myc gene amplification.
|
2267130 |
1990 |
Central neuroblastoma
|
0.060 |
PosttranslationalModification
|
disease |
BEFREE |
Our findings provide evidence for distinct patterns of Op18 phosphorylation in neuroblastoma tumors with and without N-myc gene amplification.
|
2267130 |
1990 |
Childhood Neuroblastoma
|
0.060 |
PosttranslationalModification
|
disease |
BEFREE |
Our findings provide evidence for distinct patterns of Op18 phosphorylation in neuroblastoma tumors with and without N-myc gene amplification.
|
2267130 |
1990 |
Acute lymphocytic leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We have recently identified and cloned the gene for a cytosolic polypeptide, designated oncoprotein 18 (Op18), which is expressed in acute lymphocytic leukemia and some solid tumors including neuroblastoma.
|
2267130 |
1990 |
Precursor Cell Lymphoblastic Leukemia Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We have recently identified and cloned the gene for a cytosolic polypeptide, designated oncoprotein 18 (Op18), which is expressed in acute lymphocytic leukemia and some solid tumors including neuroblastoma.
|
2267130 |
1990 |
Neuroendocrine Tumors
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Expression of phosphoprotein p19 in brain, testis, and neuroendocrine tumor cells. Developmental regulation in rat brain.
|
3042790 |
1988 |
Spinal Muscular Atrophy
|
0.100 |
Biomarker
|
disease |
BEFREE |
In both cases the patients were homozygously deleted for the survival motor neuron (SMN) gene (exons 7 and 8) but only the type I SMA patient was deleted for the neuronal apoptosis inhibitory protein (NAIP) gene (exons 5 and 6).
|
7581364 |
1995 |
Spinal Muscular Atrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This observation gives strong support to the view that mutations of the SMN gene are responsible for the SMA phenotype as it is the first frameshift mutation reported in SMA.
|
7581461 |
1995 |
Proximal spinal muscular atrophy
|
0.090 |
Biomarker
|
disease |
BEFREE |
Molecular diagnosis of childhood proximal spinal muscular atrophy has been enhanced by the discovery of the survival motor neuron (SMN) gene, which is absent or truncated in 98.6% of patients.
|
7658877 |
1995 |
Encephalitis, St. Louis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We show that the SmN gene is transcribed at significantly elevated levels in peripheral blood mononuclear cells (PBMCs) from SLE patients compared to normal controls.
|
7772706 |
1994 |
Lupus Erythematosus, Systemic
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We show that the SmN gene is transcribed at significantly elevated levels in peripheral blood mononuclear cells (PBMCs) from SLE patients compared to normal controls.
|
7772706 |
1994 |
Spinal Muscular Atrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These data suggest that this gene, termed the survival motor neuron (SMN) gene, is an SMA-determining gene.
|
7813012 |
1995 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Taken altogether, the results suggest that up-regulation Op18 levels in leukemia/lymphoma cells are strongly associated with, but not a direct cause of tumour progression.
|
8464235 |
1993 |
leukemia
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Taken altogether, the results suggest that up-regulation Op18 levels in leukemia/lymphoma cells are strongly associated with, but not a direct cause of tumour progression.
|
8464235 |
1993 |
Childhood Leukemia
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Taken altogether, the results suggest that up-regulation Op18 levels in leukemia/lymphoma cells are strongly associated with, but not a direct cause of tumour progression.
|
8464235 |
1993 |
Lymphoma
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Taken altogether, the results suggest that up-regulation Op18 levels in leukemia/lymphoma cells are strongly associated with, but not a direct cause of tumour progression.
|
8464235 |
1993 |
Adult Lymphoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Taken altogether, the results suggest that up-regulation Op18 levels in leukemia/lymphoma cells are strongly associated with, but not a direct cause of tumour progression.
|
8464235 |
1993 |
Childhood Lymphoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Taken altogether, the results suggest that up-regulation Op18 levels in leukemia/lymphoma cells are strongly associated with, but not a direct cause of tumour progression.
|
8464235 |
1993 |
Spinal Muscular Atrophy
|
0.100 |
Biomarker
|
disease |
BEFREE |
The SMN gene is homozygously deleted for both exons 7 and 8 or exon 7 only in 96% of type I SMA, 94% of type II SMA and 82% of type III SMA as well as in 0.3% of SMA parents.
|
8595417 |
1995 |
Amyotrophic Lateral Sclerosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We have therefore investigated the possibility of alterations in SMN and NAIP in 154 patients with ALS (135 sporadic cases, 17 familial cases).
|
8651652 |
1996 |
Proximal spinal muscular atrophy
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
Recently, deletions of the neuronal apoptosis inhibitory protein gene NAIP, of the survival motor neuron gene SMN, and of a further cDNA fragment, XS2G3, have been reported in childhood-onset proximal spinal muscular atrophy (SMA), another disorder with pathology restricted to the motor system.
|
8651652 |
1996 |
Spinal Muscular Atrophy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Seven index patients being not deleted for the SMN gene who belonged to a well-defined SMA plus variant that has already been shown to be unlinked with chromosome 5q markers: diaphragmatic SMA, SMA plus olivopontocerebellar hypoplasia, SMA with congenital arthrogryposis and bone fractures.2.
|
8677029 |
1996 |